Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-59
SponsorNanfang Hospital, Southern Medical University
About this trial
The purpose of the study is to verify the clinical feasibility of Benzathine penicillin (BPG) /Etanercept (ETN) combination regimen in patients with spondyloarthritis (SpA) and at the same time compare Benzathine penicillin /Etanercept combination regimen and Etanercept maintenance therapy in reducing disease activity, improving patients' clinical symptoms and body function scores, enhancing quality of life, improving imaging performance and safety.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Etanercept
- Benzathine Penicillin
- Placebo
Treatment groups
340 Participants
are divided into 2 treatment groupsLocations
6Anhui Provincial Hospital230001, HefeiAnhui, China
The Second Affiliated Hospital of Chongqing Medical University400010, ChongqingChongqing Municipality, China
Nan Fang Hospital, Southern Medical University510080, GuangzhouGuangdong, China
Nan Fang Hospital, Southern Medical University510515, GuangzhouGuangdong, China
Sponsors and collaborators
Nanfang Hospital, Southern Medical University
Lead sponsor
Source ClinicalTrials.gov